How Much Did BioBeats Raise?
Funding & Key Investors

BioBeats has successfully navigated multiple stages of capital infusion, culminating in a total funding amount of $4.6M. The company recently secured a major strategic investment of $1.7M, signaling strong market confidence in its proprietary approach to workplace mental health. This latest injection of capital underscores the firm's transition from an early-stage innovator to a significant player in the enterprise wellness sector, providing the necessary resources to scale its biometric and psychometric data platforms globally.

The growth trajectory of BioBeats reflects a consistent commitment to evidence-based health solutions. By securing backing from a diverse array of institutional investors, the company has effectively bridged the gap between academic clinical research and scalable commercial application, positioning itself as a leader in the digital health landscape.

What is BioBeats?

BioBeats
SoftwareHealthcare SoftwareMobile App Development

BioBeats operates at the intersection of digital health and organizational psychology, utilizing a sophisticated ecosystem of mobile applications and wearable technology. The company specializes in the collection and analysis of biometric and psychometric data to provide actionable insights into employee mental wellbeing. By offering organizations real-time, aggregated health metrics, BioBeats enables leadership teams to make data-driven decisions that mitigate absenteeism and foster a more resilient workforce. Their internal clinical research team remains a core differentiator, ensuring that all technological deployments are grounded in rigorous scientific validation and strict data privacy standards.

How much funding has BioBeats raised?

BioBeats has raised a total of $4.6M across 3 funding rounds:

2013

Angel/Seed

$650K

2016

Private Equity

$2.3M

2018

Other Financing Round

$1.7M

Angel/Seed (2013): $650K with participation from ZhenFund, ENIAC Ventures, and Cantora Records

Private Equity (2016): $2.3M led by White Cloud Capital, AXA Strategic Ventures, and IQ Capital

Other Financing Round (2018): $1.7M supported by IQ Capital and Oxford Sciences Innovation

Key Investors in BioBeats

IQ Capital

A venture capital firm based in Cambridge and London that specializes in deep-tech investments, including machine learning, AI, and data-focused propositions.

Oxford Science Enterprises

An independent investment company that partners with the University of Oxford to found and build transformational businesses based on world-class research.

AXA Strategic Ventures

The venture capital arm of the global insurer AXA, focusing on enterprise software, fintech, and digital health technologies.

What's next for BioBeats?

With the recent influx of capital, BioBeats is well-positioned to accelerate its product development roadmap and expand its footprint within the global enterprise market. The strategic focus will likely shift toward enhancing the predictive capabilities of their algorithms and deepening integration with existing corporate human resources platforms. As the demand for proactive mental health management continues to rise, BioBeats is poised to leverage its deep-tech foundation to capture a larger share of the corporate wellness market, potentially exploring new partnerships with global insurers and health management providers to further validate their impact on long-term employee health outcomes.

See full BioBeats company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Human Resources SoftwareSoftware
SoftwareStorage & System Management Software
Mobile App DevelopmentSoftware
Financial SoftwareSoftwareContent & Collaboration Software

Frequently Asked Questions Regarding BioBeats Financial Insights

What are the most recent funding rounds that BioBeats has completed, and what were the funding rounds?
BioBeats has recently completed 3 funding rounds: Other Financing Round on Aug 14, 2018, Private Equity on Apr 21, 2016, Angel/Seed on Jul 31, 2013.
What is the total amount of funding BioBeats has raised to date?
BioBeats has raised a total of $4.6M in funding to date.
How many funding rounds has BioBeats completed?
BioBeats has completed 3 funding rounds.
How much funding did BioBeats raise in its most recent funding round?
BioBeats raised $1.7M in its most recent funding round.
Who are the lead investors in BioBeats's latest funding round?
The lead investor in BioBeats's latest funding round was IQ Capital. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in BioBeats's history?
The largest funding round in BioBeats's history was $2.3M.
See more information about BioBeats